blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2846748

EP2846748 - SHEET AND LIQUID COMBINATION SYSTEMS FOR DERMAL DELIVERY OF LIDOCAINE, DICLOFENAC, AND OTHER DRUGS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.09.2016
Database last updated on 14.06.2024
Most recent event   Tooltip30.09.2016Application deemed to be withdrawnpublished on 02.11.2016  [2016/44]
Applicant(s)For all designated states
Zhang, Jie
6232 South Lorreen Dr.
Salt Lake City, UT 84121 / US
[2015/12]
Inventor(s)01 / see applicant
...
 [2015/12]
Representative(s)Bradley, Adrian, et al
Cleveland LLP
10 Fetter Lane
London EC4A 1BR / GB
[2015/12]
Application number, filing date13787145.508.05.2013
WO2013US40146
Priority number, dateUS201261644362P08.05.2012         Original published format: US 201261644362 P
[2015/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013169906
Date:14.11.2013
Language:EN
[2013/46]
Type: A1 Application with search report 
No.:EP2846748
Date:18.03.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 14.11.2013 takes the place of the publication of the European patent application.
[2015/12]
Search report(s)International search report - published on:US14.11.2013
(Supplementary) European search report - dispatched on:EP07.10.2015
ClassificationIPC:A61K9/70, A61K31/167, A61K31/192, A61K31/196, A61K31/445, A61P23/02
[2015/45]
CPC:
A61K9/703 (EP,US); A61K31/167 (EP,US); A61K31/192 (EP,US);
A61K31/196 (EP,US); A61K31/445 (EP,US); A61P23/02 (EP)
Former IPC [2015/12]A61F13/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/12]
TitleGerman:FOLIEN- UND FLÜSSIGKEITSKOMBINATIONSSYSTEME ZUR DERMALEN VERABREICHUNG VON LIDOCAIN, DICLOFENAC UND ANDEREN WIRKSTOFFEN[2015/12]
English:SHEET AND LIQUID COMBINATION SYSTEMS FOR DERMAL DELIVERY OF LIDOCAINE, DICLOFENAC, AND OTHER DRUGS[2015/12]
French:SYSTÈMES COMBINÉS D'UN FEUILLET ET D'UN LIQUIDE POUR L'ADMINISTRATION PERCUTANÉE DE LIDOCAÏNE, DE DICLOFÉNAC, ET D'AUTRES MÉDICAMENTS[2015/12]
Entry into regional phase04.12.2014National basic fee paid 
04.12.2014Search fee paid 
04.12.2014Designation fee(s) paid 
04.12.2014Examination fee paid 
Examination proceduredeletedCommunication of intention to grant the patent
04.12.2014Examination requested  [2015/12]
25.06.2015Amendment by applicant (claims and/or description)
03.05.2016Application deemed to be withdrawn, date of legal effect  [2016/44]
17.06.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/44]
Fees paidRenewal fee
29.04.2015Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.05.201604   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2012064766  (ZHANG JIE [US]) [XP] 1,2,4,6,9 * example 11; claim 152 *;
 [XY]US2011112189  (ZHANG JIE [US], et al) [X] 1-3,9 * example -; claim - * [Y] 1-18;
 [Y]US6120792  (JUNI JACK E [US]) [Y] 1-18 * example -; claim - *;
 [A]WO2007100910  (CURE THERAPEUTICS INC [US], et al) [A] 1-18 * example -; claim - *;
 [A]EP0223524  (NITTO ELECTRIC IND CO [JP]) [A] 1-18 * example -; claim - *;
 [A]US2007189978  (ZHANG JIE [US], et al) [A] 1-18 * example -; claim - *;
 [A]US5330452  (ZOOK GERALD P [US]) [A] 1-18 * figure -; example -; claim - *
International search[X]US4880416  (HORIUCHI TETSUO [JP], et al);
 [X]US2003004449  (LAFRATTA KELI CRISTINA [BR], et al);
 [X]US4772470  (INOUE YUICHI [JP], et al);
 [Y]US2003082225  (MASON PAUL ARTHUR [US]);
 [Y]US2007036843  (HIRSH JANE [US], et al);
 [Y]US2011112189  (ZHANG JIE [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.